Lataa...
A randomized, double‐blind, placebo‐ and positive‐controlled crossover study of the effects of durlobactam on cardiac repolarization in healthy subjects
Durlobactam (formerly ETX2514) is a diazabicyclooctane β‐lactamase inhibitor that inhibits class A, C, and D β‐lactamases. Sulbactam combined with durlobactam has in vitro and in vivo activity against Acinetobacter baumannii including carbapenem‐ and colistin‐resistant isolates and is being develope...
Tallennettuna:
| Julkaisussa: | Clin Transl Sci |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8301544/ https://ncbi.nlm.nih.gov/pubmed/33934519 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cts.12991 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|